ArticleThe pharmacogenomics journal2022

Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression Study.

Adrian I Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.